FDA.reportPublic FDA data

NDC 63323-327-21 - Nafcillin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63323-327
Requested NDC
63323-327-21
Package NDCs from labels
63323-327-21, 63323-327-10
Manufacturer
Fresenius Kabi USA, LLC | Istituto Biochimico Italiano G. Lorenzini S.p.A.
Effective date
2019-05-17
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Nafcillin for Injection, USPFresenius Kabi USA, LLC | Istituto Biochimico Italiano G. Lorenzini S.p.A.2019-05-17HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63323-327-10Nafcillin10 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,105
63323-327-21Nafcillin4 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,45

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63323-327NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]5Current NDC, Legacy NDC, 2 package rows20190518_c39721a3-7b22-4720-9dbd-bc82f03d2af7.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63323-327-10EA - Each63323-3274458849f-3ef3-411a-8d7d-6fa9f2286d1012012-07-24
63323-327-21EA - Each63323-32781dc295b-e34a-490d-a39b-47df646ecc0212025-11-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAFCILLIN SODIUMACTIVE INGREDIENT49G3001BCKNAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC]2
NAFCILLINACTIVE MOIETY4CNZ27M7RVNAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRNAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 48 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NafcillinNAFCILLINWG Critical Care, LLC4d3b0076-3780-413f-9052-b23be5f18f012026-08-25Warnings, Adverse reactionsExact identifier
rxcui: 1721458
rxcui: 1721460
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMHeritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.8a00624c-c436-4102-a042-dab54022bcc22026-07-28Warnings, Adverse reactionsExact identifier
rxcui: 1721458
rxcui: 1721460
unii: 49G3001BCK
Leukotrap WB SystemCPDA-1 BLOOD BAG COLLECTION SYSTEMGVS TM INC54fd8a72-0527-df0c-e063-6294a90abe752026-06-24Exact identifier
unii: 1Q73Q2JULR
Leukotrap WB SystemCPDA-1 BLOOD BAG COLLECTION SYSTEMGVS TM INC54fddca1-b40c-7af0-e063-6294a90a410e2026-06-24Exact identifier
unii: 1Q73Q2JULR
Leukotrap WB SystemCPDA-1 BLOOD BAG COLLECTION SYSTEMGVS TM INC54fdf83e-f641-1f69-e063-6394a90ab7502026-06-24Exact identifier
unii: 1Q73Q2JULR
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATECardinal Health 107, LLCb3d5225c-0ee4-481e-b9ec-bc5e1321096d2026-06-12Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACIDChartwell Governmental & Specialty RX, LLC58c24504-47de-487a-ab8d-18add155ea952026-04-07Adverse reactionsExact identifier
unii: 1Q73Q2JULR
NAFCILLIN SODIUMNAFCILLIN SODIUMONESOURCE SPECIALTY PHARMA LIMITED4b3b8e52-df96-4886-e063-6294a90ac63f2026-03-09Warnings, Adverse reactionsExact identifier
rxcui: 1721458
rxcui: 1721460
unii: 49G3001BCK
TricitratesTRICITRATESChartwell Governmental & Specialty RX, LLC.c4ff0407-3930-4c48-afd4-d2cb3e1b18f42026-02-25Warnings, Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATEAtlantic Biologicals Corp.42d837ae-2578-46df-92d2-24774964aaad2026-01-28Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Sterile Cord Blood Collection Unit (MSC128D)ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTIONMaco Productions251fd4cb-4aa4-4473-9f89-968da856eb772025-12-18WarningsExact identifier
unii: 1Q73Q2JULR
Sterile Cord Blood Collection Unit (MSC127D)ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTIONMaco Productions75a008b2-9666-4bfa-ab18-6d09b43b22152025-12-18WarningsExact identifier
unii: 1Q73Q2JULR
Pall Sterile Cord Blood Collection UnitSTERILE CORD BLOOD COLLECTION UNITGlobal Life Sciences Solutions USA LLCaa9340b7-cc63-e17d-e053-2a95a90ad4d92025-12-18WarningsExact identifier
unii: 1Q73Q2JULR
STERILE CORD BLOOD COLLECTION UNIT (MSC123D)ANTICOAGULANT CITRATE PHOSPHATE DEXTROSEMaco Productionse3b456ec-4578-485f-a696-8a343505f30b2025-12-16WarningsExact identifier
unii: 1Q73Q2JULR
PaxLyteLEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULEJaymac Pharmaceuticalsf520b130-61b3-443e-aaf6-91e094e7a3342025-12-08Warnings, Adverse reactionsExact identifier
unii: 1Q73Q2JULR
ACD-AANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA AFenwal, Inc.ab19b011-0a51-4f04-9881-d9fc7cae95ae2025-11-25Exact identifier
unii: 1Q73Q2JULR
NAFCILLIN SODIUMNAFCILLIN SODIUMArmas Pharmaceuticals Inc.090fda61-b9c8-640e-e063-6294a90a73632025-09-30Warnings, Adverse reactionsExact identifier
rxcui: 1721458
rxcui: 1721460
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMEugia US LLC90717878-64cb-4ffc-90bc-7b4e81e3d1cd2025-08-16Warnings, Adverse reactionsExact identifier
rxcui: 1721458
rxcui: 1721460
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMEugia US LLC8ec288e6-4d7f-4fea-a5ab-f9f337ebaa862025-08-16Warnings, Adverse reactionsExact identifier
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMEugia US LLC34821770-929c-40ea-a9e4-d4405dc869e12025-08-12Warnings, Adverse reactionsExact identifier
rxcui: 1721460
unii: 49G3001BCK

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.